【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Global IVD Products and Test Market
Market Size
Market Forecast
06.2 Five Forces Analysis
07. Market Growth Drivers
08. Drivers and their Impact
09. Market Challenges
10. Impact of Drivers and Challenges
11. Market Trends
12. Market Segmentation
13. Volume Analysis
13.1 POC Test
OTC Tests
Professional Tests
Volume Analysis of POC Tests
Volume Trends
13.2 Core Laboratory Test
Key Segmentation
Clinical Chemistry
Immunoassay
Volume Analysis of Core Laboratory Tests
Volume Trends
13.3 Molecular Test
Key Segmentation
Infectious Diseases
Oncology
Inherited Diseases
Other Tests
Volume Analysis of Molecular Test
Volume Trends
13.4 Haematology Test
Volume Analysis by Test Type
Volume Trends
13.5 Coagulation Test
Key Segmentation
International Normalized Ratio
Activated Thromboplastin Time
Volume Analysis by Test Type
Volume Trends
13.6 Microbiology Test
Key Segmentation
Automated Panels and Reagents
Blood Culture
Chromogenic Media
Manual Panels and Reagents
Volume Analysis by Test Type
Volume Trends
13.7 Blood Banking Test
Volume Analysis by Test Type
Volume Trends
13.8 Histology/Cytology Test
Key Segmentation
Pap Stains
Non-pap Stains
Image Cytometry
Flow Cytometry
IHC and ISH
Circulating Tumour Cells
Volume Analysis by Test Type
Volume Trends
14. Pricing Analysis
14.1 POC Test
Market Overview
Major Products
Pricing Trends
14.2 Core Laboratory Test
Market Overview
Major Products
Pricing Trends
14.3 Molecular Test
Market Overview
Major Products
Pricing Trends
14.4 Haematology Test
Market Overview
Major Products
Pricing Trends
14.5 Coagulation Test
Market Overview
Major Products
Pricing Trends
14.6 Microbiology Test
Market Overview
Major Products
Pricing Trends
14.7 Blood Banking Test
Market Overview
Major Products
Pricing Trends
14.8 Histology/Cytology Test
Market Overview
Major Products
Pricing Trends
15. Geographical Segmentation
16. Key Leading Countries
US
Germany
Japan
17. Vendor Landscape by Sales
18. Vendor Landscape by Volume
19. Buying Criteria
20. Key Vendor Analysis
20.1 Abbott Laboratories
Business Overview
Key Information
SWOT Analysis
20.2 Becton Dickinson and Company
Business Overview
Key Information
SWOT Analysis
20.3 bioMerieux SA
Business Overview
Key Information
SWOT Analysis
20.4 F. Hoffmann-La Roche Ltd.
Business Overview
Key Information
SWOT Analysis
20.5 Siemens Healthcare
Business Overview
Key Information
SWOT Analysis
21. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global IVD Products and Test Market by Sales 2012-2016 (US$ million)
Exhibit 3: Global IVD Products and Test Market by Volume 2012-2016 (in million units)
Exhibit 4: Global IVD Products and Test Market by Category Segmentation
Exhibit 5: Global IVD Products and Test Market Sales by Category Segmentation 2012
Exhibit 6: Global IVD Products and Test Market Sales by Category Segmentation 2012-2016
Exhibit 7: Global IVD Products and Test Market Volume by Category Segmentation 2012
Exhibit 8: Global IVD Products and Test Market Volume by Category Segmentation 2016-2016
Exhibit 9: POC Test Procedure by Category Segmentation
Exhibit 10: POC Test Procedure Volume by Category Segmentation 2012
Exhibit 11: Global Procedure Volume of OTC Tests 2012-2016 (in million units)
Exhibit 12: OTC Test Procedure Volume by Category Segmentation 2012
Exhibit 13: Global OTC Test Sales 2012-2016 (in US$ million)
Exhibit 14: Global OTC Test Sales by Category Segmentation 2012
Exhibit 15: Global Procedure Volume of Glucose Tests 2012-2016 (in million units)
Exhibit 16: Global Glucose Test Sales 2012-2016 (in US$ million)
Exhibit 17: Global Procedure Volume of Pregnancy/Ovulation Tests 2012-2016 (in million units)
Exhibit 18: Global Pregnancy/Ovulation Test Sales 2012-2016 (in US$ million)
Exhibit 19: Global Procedure Volume of Other Tests 2012-2016 (in million units)
Exhibit 20: Global Other Test Sales 2012-2016 (in US$ million)
Exhibit 21: Global Procedure Volume of Professional Tests 2012-2016 (in millions units)
Exhibit 22: Professional Test Procedure Volume by Category Segmentation 2012
Exhibit 23: Global Professional Test Sales 2012-2016 (in US$ million)
Exhibit 24: Global Professional Test Sales by Category Segmentation 2012
Exhibit 25: Global Procedure Volume of Glucose Tests 2012-2016 (in million units)
Exhibit 26: Global Glucose Test Sales 2012-2016 (in US$ million)
Exhibit 27: Global Procedure Volume of Infectious Disease Tests 2012-2016 (in million units)
Exhibit 28: Global Infectious Disease Test Sales 2012-2016 (in US$ million)
Exhibit 29: Global Procedure Volume of Critical Care Tests 2012-2016 (in million units)
Exhibit 30: Global Critical Care Test Sales 2012-2016 (in US$ million)
Exhibit 31: Global Procedure Volume of Other Tests 2012-2016 (in millions)
Exhibit 32: Global Other Test Sales 2012-2016 (in US$ million)
Exhibit 33: Global Procedure Volume of POC Tests 2012-2016 (in million units)
Exhibit 34: Core Laboratory Test Procedure by Category Segmentation
Exhibit 35: Core Laboratory Test Procedure Volume by Category Segmentation 2012
Exhibit 36: Global Procedure Volume of Clinical Chemistry Test 2012-2016 (in million units)
Exhibit 37: Clinical Chemistry Test Procedure Volume by Category Segmentation 2012
Exhibit 38: Global Clinical Chemistry Test Sales 2012-2016 (in US$ million)
Exhibit 39: Global Clinical Chemistry Test Sales by Category Segmentation 2012
Exhibit 40: Global Procedure Volume of General Chemistry Test 2012-2016 (in millions units)
Exhibit 41: Global General Chemistry Test Sales 2012-2016 (in US$ million)
Exhibit 42: Global Procedure Volume of Blood Gas Analysis 2012-2016 (in million units)
Exhibit 43: Global Blood Gas Analysis Sales 2012-2016 (in US$ million)
Exhibit 44: Global Procedure Volume of Urinalysis 2012-2016 (in million units)
Exhibit 45: Global Urinalysis Sales 2012-2016 (in US$ million)
Exhibit 46: Global Procedure Volume of Immunoassay 2012-2016 (in million units)
Exhibit 47: Immunoassay Procedure Volume by Category Segmentation 2012
Exhibit 48: Global Immunoassay Sales 2012-2016 (in US$ million)
Exhibit 49: Global Immunoassay Sales by Category Segmentation 2012
Exhibit 50: Global Procedure Volume of Infectious Disease Tests 2012-2016 (in million units)
Exhibit 51: Global Infectious Disease Test Sales 2012-2016 (in US$ million)
Exhibit 52: Global Procedure Volume of Cardiac Markers 2012-2016 (in million units)
Exhibit 53: Global Cardiac Marker Sales 2012-2016 (in US$ million)
Exhibit 54: Global Procedure Volume of Tumour Markers 2012-2016 (in million units)
Exhibit 55: Global Tumour Marker Sales 2012-2016 (in US$ million)
Exhibit 56: Global Procedure Volume of Diabetes Tests 2012-2016 (in million units)
Exhibit 57: Global Diabetes Test Sales 2012-2016 (in US$ million)
Exhibit 58: Global Procedure Volume of Autoimmune Disease Tests 2012-2016 (in million units)
Exhibit 59: Global Autoimmune Disease Test Sales 2012-2016 (in US$ million)
Exhibit 60: Global Procedure Volume of Other Tests 2012-2016 (in million units)
Exhibit 61: Global Other Tests Sales 2012-2016 (in US$ million)
Exhibit 62: Global Procedure Volume of Core Laboratory Tests 2012-2016 (in millions)
Exhibit 63: Molecular Test Procedure by Category Segmentation
Exhibit 64: Molecular Test Procedure Volume by Category Segmentation 2012
Exhibit 65: Global Procedure Volume of Infectious Disease Tests 2012-2016 (in millions)
Exhibit 66: Global Infectious Disease Test Sales 2012-2016 (in US$ million)
Exhibit 67: Global Procedure Volume of Oncology Tests 2012-2016 (in millions)
Exhibit 68: Global Oncology Test Sales 2012-2016 (in US$ million)
Exhibit 69: Global Procedure Volume of Inherited Disease Tests 2012-2016 (in million units)
Exhibit 70: Global Inherited Disease Test Sales 2012-2016 (in US$ million)
Exhibit 71: Global Procedure Volume of Other Tests 2012-2016 (in million units)
Exhibit 72: Global Other Test Sales 2012-2016 (in US$ million)
Exhibit 73: Global Procedure Volume of Molecular Test 2012-2016 (in millions)
Exhibit 74: Global Procedure Volume of Haematology Test 2012-2016 (in million units)
Exhibit 75: Coagulation Test Procedure by Category Segmentation
Exhibit 76: Global Procedure Volume of Coagulation Test 2012-2016 (in millions)
Exhibit 77: Microbiology Test Procedure by Category Segmentation
Exhibit 78: Microbiology Test Procedure Volume by Category Segmentation 2012
Exhibit 79: Global Procedure Volume of Automated Panels and Reagents 2012-2016 (in millions)
Exhibit 80: Global Automated Panels and Reagents Sales 2012-2016 (in US$ million)
Exhibit 81: Global Procedure Volume of Blood Culture 2012-2016 (in million units)
Exhibit 82: Global Blood Culture Sales 2012-2016 (in US$ million)
Exhibit 83: Global Procedure Volume of Chromogenic Media Test 2012-2016 (in million units)
Exhibit 84: Global Chromogenic Media Test Sales 2012-2016 (in US$ million)
Exhibit 85: Global Procedure Volume of Manual Panels and Reagents 2012-2016 (in million units)
Exhibit 86: Global Manual Panels and Reagents Sales 2012-2016 (in US$ million)
Exhibit 87: Global Procedure Volume of Microbiology Test 2012-2016 (in millions)
Exhibit 88: Global Procedure Volume of Blood Banking Tests 2012-2016 (in million units)
Exhibit 89: Histology/Cytology Test Procedure by Category Segmentation
Exhibit 90: Histology/Cytology Test Procedure Volume by Category Segmentation 2012
Exhibit 91: Global Procedure Volume of Pap Stains 2012-2016 (in million units)
Exhibit 92: Global Pap Stains Sales 2012-2016 (in US$ million)
Exhibit 93: Global Procedure Volume of Non-pap Stains 2012-2016 (in million units)
Exhibit 94: Global Non-pap Stains Sales 2012-2016 (in US$ million)
Exhibit 95: Global Procedure Volume of Image Cytometry 2012-2016 (in million units)
Exhibit 96: Global Image Cytometry Sales 2012-2016 (in US$ million)
Exhibit 97: Global Procedure Volume of Flow Cytometry 2012-2016 (in million units)
Exhibit 98: Global Flow Cytometry Sales 2012-2016 (in US$ million)
Exhibit 99: Global Procedure Volume of IHC Tests 2012-2016 (in million units)
Exhibit 100: Global IHC Test Sales 2012-2016 (in US$ million)
Exhibit 101: Global Procedure Volume of ISH Tests 2012-2016 (in million units)
Exhibit 102: Global ISH Test Sales 2012-2016 (in US$ million)
Exhibit 103: Global Procedure Volume of CTC Tests 2012-2016 (in million units)
Exhibit 104: Global CTC Test Sales 2012-2016 (in US$ million)
Exhibit 105: Global Procedure Volume of Histology/Cytology Test 2012-2016 (in million units)
Exhibit 106: Global POC Test Sales 2012-2016 (in US$ million)
Exhibit 107: Global POC Test Sales by Category Segmentation 2012
Exhibit 108: Global Core Laboratory Test Sales 2012-2016 (in US$ million)
Exhibit 109: Global Core Laboratory Test Sales by Category Segmentation 2012
Exhibit 110: Global Molecular Test Sales 2012-2016 (in US$ million)
Exhibit 111: Global Molecular Test Sales by Category Segmentation 2012
Exhibit 112: Global Haematology Test Sales 2012-2016 (in US$ million)
Exhibit 113: Global Coagulation Test Sales 2012-2016 (in US$ million)
Exhibit 114: Global Microbiology Test Sales 2012-2016 (in US$ million)
Exhibit 115: Global Microbiology Test Sales by Category Segmentation 2012
Exhibit 116: Global Blood Banking Test Sales 2012-2016 (in US$ million)
Exhibit 117: Global Histology/Cytology Test Sales 2012-2016 (in US$ million)
Exhibit 118: Global Histology/Cytology Test Sales by Category Segmentation 2012
Exhibit 119: Global IVD Products and Test Market by Geographical Segmentation 2012
Exhibit 120: Vendor Segmentation of Global IVD Products and Test Market by Sales 2012
Exhibit 121: Vendor Segmentation of Global IVD Products and Test Market by Volume 2012
Exhibit 122: Business Segmentation of Abbott Laboratories
Exhibit 123: Business Segmentation of Becton Dickinson and Company
Exhibit 124: Business Segmentation of bioMerieux SA
Exhibit 125: Business Segmentation of Hoffmann-La Roche Ltd.
Exhibit 126: Business Segmentation of Siemens Healthcare
【レポート販売概要】
■ タイトル：世界のIVD製品及びテスト市場（2012-2016）■ 英文：Global?IVD?Products?and?Test?Market?- Strategic?Volume?and?Pricing?Analysis?2012-2016
■ 発行日：2013年7月12日
■ 調査会社：Technavio
■ 商品コード：IRTNTR2307
■ 調査対象地域：グローバル
- 多要素認証ソリューションの世界市場：スマートカード認証、携帯電話認証、OTPハードウェアトークンAbout Multi-factor Authentication Multi-factor authentication solutions are security systems that require two or more types of authentication to verify a transaction. In addition, it acts as a security layer and makes it difficult for an unauthorized person to access a physical location, database, or computing device. Earlier, the majority of systems relied upon two-factor authentication unlike th …
- ハイブリッドクラウドの世界市場2019-2023About this market The ability of hybrid clouds to simplify disaster recovery will trigger the hybrid cloud market growth during the forecast period. Hybrid cloud solutions simplify the overall management in a disaster recovery setup. In addition, hybrid cloud model also allows businesses in scaling up their operations up or down as required. Cloud solutions have a very high scalability, in turn, a …
- インスリン抵抗性（Insulin Resistance）：グローバル臨床試験レビュー（2014年上半期）Insulin Resistance Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Insulin Resistance Global Clinical Trials Review, H1, 2014" provides data on the Insulin Resistance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Insulin Resistance. It includes an overview of the trial numbers and their recruitme …
- ドメインネームシステム（DNS）ツールの世界市場2016-2020About Domain Name System Tools DNS is a decentralized naming system for computers, services, or any resource connected to the Internet or a private network. It consists of various information with domain names assigned to each of the participating entities. It translates the domain names into the numerical Internet protocol (IP) addresses required for identifying computer services and devices with …
- 船舶用電源装置の世界市場About Marine Power Systems The marine auxiliary engine is used to generate electricity onboard marine vessels, which is termed as an auxiliary unit. Initially, steam turbine propulsion was used, which was later replaced by diesel, LNG, nuclear, and other fuels. Nuclear propulsion is used for naval purposes for its fast movement, and the other type of fuel ships are used for the commercial purposes …
- イギリスの診断市場：：市場動向と展望This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: - Blood Banking - Cancer - Chemistry & …
- 自立式遊具の世界市場2017-2021ABSTRACTAbout Freestanding Playground Equipment Freestanding playground equipment refers to commercial playground equipment that is available at schools, playschools, and parks. Slides, swings, and climbers, are the most common types of freestanding playground equipment. Others such as seesaws, spring riders, and rope courses are also popular. Freestanding playground equipment refers to commercial …
- 世界におけるバイオメトリック（生体認証）システム市場2013-2023（SWOT分析）Synopsis This report provides readers with an exhaustive analysis of industry characteristics, determining the strengths, weaknesses, opportunities and threats faced by the Biometric System market. Summary This SWOT analysis of Biometric System market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Biometric System Ma …
- インドの農業の機械化市場2016-2020About Farm Mechanization The global farm mechanization market is largely dependent on agricultural land and farm output. Global agricultural production affects the market substantially as it grows in tandem with the demand for food. However, in various phases, the global agricultural production has slowed down in recent years as the demand for agricultural products has decreased. Recent environmen …
- 放射線治療の世界市場予測（～2023年）“The radiotherapy market is projected to grow at a CAGR of 4.1% during the forecast period”The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1%. Growth in this market is largely driven by factors such as the growing global prevalence of cancer, increasing adoption of radiotherapy in clinical trials, and the increasing number o …
- 電動スクーター用電池の世界市場：鉛蓄電池、ニッケル・水素充電池、リチウムイオン電池About E-Scooters E-bikes and E-scooters are different from each other. E-bikes have traditional bicycle designs, but they include a battery pack, controller, and an electric hub motor on the front wheel, rear wheel, or both wheels, and they have pedals. On the other hand, E-scooters look like traditional liquid fuel powered scooters, the only difference being that E-scooters are not equipped with …
- 世界のDCS（分散制御システム）市場（2014-2018）About DCS A DCS is an automated control system that, rather than being centralized, is distributed across an entire organization. Such systems are distributed in such a way that each component or subsystem of a manufacturing plant is controlled by one or more controllers, thereby providing instructions to different parts of the plant. Thus, instead of having a centrally located control system, eac …
- 非アルコール性脂肪性肝疾患(NAFLD)：世界の治験レビュー（2015年上半期版）Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015" provides data on the Non Alcoholic Fatty Liver Disease (NAFLD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non Alcoholic F …
- 世界の携帯式対戦車・対空短距離ミサイル及びRPG市場動向及び予測（2014 – 2020）The global shoulder fired anti-tank, anti-aircraft and RPG market for man-portable anti-armor weapons is expected to be $3.2 billion in 2014 and the market will produce around $1.9 million weapons by the end of 2020. The current CAGR is 6.03%. The shoulder fired missile market in the U.S. is expected to grow from $1,185.60 million in 2014 to $1237.01 million in 2020 at an estimated CAGR of 1%. The …
- Spectra Energy Corp：石油・ガスバリューチェーン分析レポート2013Spectra Energy Corp Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Spectra Energy Corp" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Spectra Energy Corp”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
